AI-Driven Manufacturing and Quality Assurance
Artificial Intelligence (AI) has become foundational to generic drug production in 2026. Manufacturers are utilizing AI to streamline every stage of the lifecycle, from molecule identification to real-time safety monitoring.
Accelerated Development: AI platforms using natural language processing (NLP) automate the analysis of vast regulatory databases, helping manufacturers identify the most efficient approval pathways.
Predictive Maintenance: Automated production lines in hubs like Ahmedabad and Dublin now use predictive analytics to reduce batch deviations, ensuring consistent drug quality while minimizing waste.
1 View